•
Mar 31, 2019

Lexicon Pharmaceuticals Q1 2019 Earnings Report

Total Revenue
$9.22M
Previous year: $25.2M
-63.4%
EPS
-$0.21
Previous year: -$0.4
-47.5%
Research and development expenses
$12M
Selling, general and admin expenses
$14.1M
Gross Profit
$8.66M
Cash and Equivalents
$45.8M
Free Cash Flow
-$25.7M
Total Assets
$259M

Lexicon Pharmaceuticals

Lexicon Pharmaceuticals

Lexicon Pharmaceuticals Revenue by Segment

Revenue & Expenses

Visualization of income flow from segment revenue to net income